Back to News
Market Impact: 0.1
Adial Pharmaceuticals, Inc. Announces Name Change to Azora Therapeutics, Inc. and New Executive Appointments on October 28, 2026
Source: Nasdaq
Management & GovernanceCompany Fundamentals
Adial Pharmaceuticals stockholders approved an amendment to change the company’s name to Azora Therapeutics, Inc. and increase the authorized number of common shares; the article provides no share-count details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- DoorDash offers $17 billion for Instacart: ‘the largest companies are only eating more and more of the pie’
- Alphabet Erases $500 Billion as ChatGPT, Google AI Cut into Search
- Alphabet just had its worst day as a public company. BofA now values Google search at a lower multiple than fossil fuel stocks
- Norwegian shares surge 13% on earnings beat, guidance raise
- ECB’s Lagarde Steps Aside as European Economic Pressure Builds
- PC chip plunge wipes out a quarter of Intel’s value